tirzepatide vs semaglutide weight loss trials New study result 🚨 SURMOUNT 5 RCT 📉Total body loss: −20.2% with tirzepatide −13.7% with semaglutide 🤢Discontinuations due to gastrointestinal events:… Tirzepatide causes more weight loss

Research is also exploring retatrutide for MASH, where its combination of weight loss, metabolic improvement, and specific hepatic fat-reducing effects from glucagon receptor activation could address multiple aspects of liver disease pathophysiology

This can create a positive feedback loop, where the initial weight loss encourages further healthy behaviors, ultimately leading to sustained success over the long term

having a phone number to call for help (13%) and having access to help resources online (12%)

But that framing obscures the logic embedded in what the policy retained and what it eliminated

Your gut produces most of the GLP-1 in your body The L-cells that produce GLP-1 live in your intestinal lining, with the highest concentrations in the ileum (the last section of your small intestine) and the colon